These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10369632)

  • 1. Neuroleptic malignant syndrome associated with metoclopramide.
    Nonino F; Campomori A
    Ann Pharmacother; 1999 May; 33(5):644-5. PubMed ID: 10369632
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome induced by metoclopramide in an infant with Freeman-Sheldon syndrome.
    Stein MH; Sorscher M; Caroff SN
    Anesth Analg; 2006 Sep; 103(3):786-7. PubMed ID: 16931708
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea.
    Supariwala A; Kant G; Jean RE
    Intensive Care Med; 2011 Oct; 37(10):1706-8. PubMed ID: 21688103
    [No Abstract]   [Full Text] [Related]  

  • 4. Metoclopramide-induced neuroleptic malignant syndrome.
    Friedman LS; Weinrauch LA; D'Elia JA
    Arch Intern Med; 1987 Aug; 147(8):1495-7. PubMed ID: 3632154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome induced by metoclopramide.
    Donnet A; Harle JR; Dumont JC; Alif Cherif A
    Biomed Pharmacother; 1991; 45(10):461-2. PubMed ID: 1820178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant-like syndrome induced by metoclopramide.
    Samie MR
    Mov Disord; 1987; 2(1):57-60. PubMed ID: 3504260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome associated with metoclopramide.
    Patterson JF
    South Med J; 1988 May; 81(5):674-5. PubMed ID: 3368821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome associated with metoclopramide in a child.
    Yaman A; Kendirli T; Ödek Ç; Yıldız C; Beğde F; Erkol H; İnce E
    Turk J Pediatr; 2014; 56(5):535-7. PubMed ID: 26022591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome associated with metoclopramide in a burn patient.
    Nachreiner R; Balledux J; Zieger M; Viegas O; Sood R
    J Burn Care Res; 2006; 27(2):237-41. PubMed ID: 16566575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome.
    Bristow MF; Kohen D
    Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome associated with metoclopramide.
    Cassidy T; Bansal SK
    Br Med J (Clin Res Ed); 1988 Jan; 296(6616):214. PubMed ID: 3123006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria].
    Krähenbühl S; Raisin J; Herren T
    Schweiz Med Wochenschr; 1993 Jul; 123(26):1359-62. PubMed ID: 8342005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome associated with metoclopramide.
    Robinson MB; Kennett RP; Harding AE; Legg NJ; Clarke B
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1304. PubMed ID: 4087008
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome associated with only one dose of metoclopramide in an older adult.
    Kocyigit SE; Soysal P; Isik AT
    Geriatr Gerontol Int; 2017 Aug; 17(8):1232-1233. PubMed ID: 28849625
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome in a child treated with metoclopramide for chemotherapy-related nausea.
    Brower RD; Dreyer CF; Kent TA
    J Child Neurol; 1989 Jul; 4(3):230-2. PubMed ID: 2768791
    [No Abstract]   [Full Text] [Related]  

  • 16. Metoclopramide in a patient with renal failure may be an increased risk of neuroleptic malignant syndrome.
    Fujita Y; Yasukawa T; Mihira M; Sasaki T; Yokoya S
    Intensive Care Med; 1996 Jul; 22(7):717. PubMed ID: 8844247
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed neuroleptic malignant syndrome following cessation of prolonged therapy with metoclopramide.
    Le Couteur DG; Kay T
    Aust N Z J Med; 1995 Jun; 25(3):261. PubMed ID: 7487703
    [No Abstract]   [Full Text] [Related]  

  • 18. Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene.
    Henderson A; Longdon P
    Aust N Z J Med; 1991 Oct; 21(5):742-3. PubMed ID: 1759924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance.
    Morita T; Shishido H; Tei Y; Inoue S; Nagayama K
    J Palliat Med; 2004 Dec; 7(6):861-4. PubMed ID: 15684854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant neuroleptic syndrome linked to haloperidol].
    Espino García A; Madrid Valls M; Mur Garcés R; Nadal Braqué N
    Aten Primaria; 2001 May; 27(9):677. PubMed ID: 11412563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.